Spirulina and post-COVID fatigue.

Post-COVID fatigue pathophysiology

• Persistent microglial activation:PET studies (TSPO ligands) and post-mortem brain tissue from Long COVID patients show sustained microglial activation in brainstem, cerebellum, and cortical regions. Microglial NOX2 produces superoxide that damages nearby neurons and oligodendrocytes, contributing to brain fog, fatigue, and autonomic dysfunction. This is mechanistically identical to the microglial pathology in ME/CFS.
• Mitochondrial dysfunction:Post-COVID skeletal muscle biopsies document reduced Complex I and Complex III activity, impaired oxidative phosphorylation, and increased lactate production at rest. This mirrors ME/CFS mitochondrial pathology. The result is ATP depletion on demand — exertion that previously required no recovery now causes multi-day relapse (post-exertional malaise, PEM).
• NADPH oxidase in endothelium:SARS-CoV-2 spike protein activates endothelial NOX2 directly via ACE2 signalling. Persistent endothelial NOX2 activation produces superoxide that scavenges nitric oxide, reducing vasodilation and microvascular perfusion — contributing to orthostatic intolerance and tissue hypoxia.
• Mast cell activation:Mast cell activation syndrome (MCAS) is disproportionately prevalent in Long COVID. Mast cell degranulation releases histamine, tryptase, and prostaglandins that drive fatigue, brain fog, and autonomic symptoms. The GLA/DGLA fatty acid pathway in spirulina competes with arachidonic acid for 5-LOX, reducing leukotriene production from mast cells.

Iron and haematological complications

• Hyperferritinaemia masking depletion:Acute COVID-19 causes extreme ferritin elevation (ferritin is an acute-phase reactant). In recovery, ferritin falls — but may remain elevated for months while true iron stores are depleted. The ferritin reading overestimates iron status in the post-acute phase. Transferrin saturation (<20%) and soluble transferrin receptor (>2.5 mg/L) are more reliable markers of functional iron deficiency in this context.
• Haemolysis:SARS-CoV-2 causes haemolytic anaemia in some patients. Red cell survival is reduced; haemoglobin falls. Combined with poor appetite and reduced absorption during illness, iron deficiency is common post-COVID.
• Spirulina’s iron (4–8 mg/5 g depending on form) is relevant for post-COVID iron repletion — but check transferrin saturation, not just ferritin, before supplementing. If ferritin remains elevated (>200 µg/L) with normal transferrin saturation, hold iron-containing supplements.

PEM and the start-low imperative

• Post-exertional malaise (PEM) — symptom worsening triggered by physical or cognitive exertion — is the hallmark of ME/CFS-overlap Long COVID. Any new supplement or intervention can trigger PEM in sensitised patients if introduced at standard doses.
• Start spirulina at 0.5 g/day for the first week. Increase by 0.5 g every 1–2 weeks, monitoring for 24–48 hour delayed worsening (the typical PEM window). Target dose 3–5 g/day over 6–8 weeks if tolerated.
• If any PEM-like worsening occurs after a dose increase, return to the previous dose and wait 2 weeks before attempting to increase again.

Phycocyanobilin mechanisms in post-COVID context

• NOX2 inhibition in microglia: reduces the superoxide production driving brain fog and neuroinflammatory fatigue. The same mechanism applies to endothelial NOX2 activated by persistent spike protein signalling.
• NF-κB inhibition: reduces cytokine production (IL-6, IL-1β, TNF-α) that drives the ongoing immune activation in Long COVID. Elevated IL-6 directly suppresses mitochondrial biogenesis via PGC-1α suppression — the same mitochondrial pathway deficient in post-COVID fatigue.
• No clinical trial of spirulina or phycocyanin in Long COVID or ME/CFS exists. The mechanistic alignment is among the strongest of any condition covered on this site; clinical evidence is absent.

Practical guidance

• Start 0.5 g/day; increase 0.5 g every 1–2 weeks; target 3–5 g/day. Monitor for PEM at each increase.
• Check transferrin saturation before assuming iron supplementation is appropriate — do not rely on ferritin alone in post-COVID context
• Take in cold format (shots, cold water) — phycocyanin is preserved; easy on the digestive system for patients with post-COVID GI symptoms
• Inform GP or Long COVID clinic of all supplements — particularly relevant if anticoagulated (some Long COVID patients receive anticoagulation for microclot burden)
• The antiplatelet effect of spirulina is mild but relevant if the patient is on anticoagulants — discuss with prescriber